A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer

NCT04439890 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

369

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Non-squamous Cell Non-small Cell Lung Cancer

Interventions

DRUG: Anlotinib hydrochloride capsule
DRUG: Carboplatin injection
DRUG: Pemetrexed disodium f Injection
DRUG: Placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.